Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Garber

Showing results (31-40 of 393) with videos related to

Pageof 40
Sort By:
The Lancet. Diabetes & Endocrinology|March 14, 2014
The importance of incretin therapies for managing type 2 diabetesAlan J Garber
Geriatric Nursing (New York, N.Y.)|May 1, 1988
The other side of the coinL J Garber
The Medical Clinics of North America|August 26, 1998
Vascular disease and lipids in diabetesA J Garber
Diabetes, Obesity & Metabolism|February 15, 2002
Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practiceAlan J Garber
Drugs|January 10, 2006
Premixed insulin analogues for the treatment of diabetes mellitusAlan J Garber
Diabetes, Obesity & Metabolism|May 15, 2013
Treat-to-target trials: uses, interpretation and review of conceptsA J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 19, 2013
In responseAlan J Garber
Diabetes, Obesity & Metabolism|October 15, 2013
Will the next generation of basal insulins offer clinical advantages?A J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IN RESPONSE TO AUTHORS' RESPONSE TO KARL Z. NADOLSKY, DO, RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARYAlan J Garber,
Diabetes, Obesity & Metabolism|March 13, 2012
Current challenges in type 2 diabetesA J Garber
Pageof 40

Showing results (31-40 of 393) with videos related to

Sort By:
Pageof 40
The Lancet. Diabetes & Endocrinology|March 14, 2014
The importance of incretin therapies for managing type 2 diabetesAlan J Garber
Geriatric Nursing (New York, N.Y.)|May 1, 1988
The other side of the coinL J Garber
The Medical Clinics of North America|August 26, 1998
Vascular disease and lipids in diabetesA J Garber
Diabetes, Obesity & Metabolism|February 15, 2002
Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practiceAlan J Garber
Drugs|January 10, 2006
Premixed insulin analogues for the treatment of diabetes mellitusAlan J Garber
Diabetes, Obesity & Metabolism|May 15, 2013
Treat-to-target trials: uses, interpretation and review of conceptsA J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 19, 2013
In responseAlan J Garber
Diabetes, Obesity & Metabolism|October 15, 2013
Will the next generation of basal insulins offer clinical advantages?A J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IN RESPONSE TO AUTHORS' RESPONSE TO KARL Z. NADOLSKY, DO, RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARYAlan J Garber,
Diabetes, Obesity & Metabolism|March 13, 2012
Current challenges in type 2 diabetesA J Garber
Pageof 40